328 related articles for article (PubMed ID: 18582541)
21. The interactive effects of nicotinic and muscarinic cholinergic receptor inhibition on fear conditioning in young and aged C57BL/6 mice.
Feiro O; Gould TJ
Pharmacol Biochem Behav; 2005 Feb; 80(2):251-62. PubMed ID: 15680178
[TBL] [Abstract][Full Text] [Related]
22. Dorsal hippocampal administration of triiodothyronine enhances long-term memory for trace cued and delay contextual fear conditioning in rats.
Sui L; Wang F; Liu F; Wang J; Li BM
J Neuroendocrinol; 2006 Nov; 18(11):811-9. PubMed ID: 17026530
[TBL] [Abstract][Full Text] [Related]
23. The role of dorsal hippocampus and basolateral amygdala NMDA receptors in the acquisition and retrieval of context and contextual fear memories.
Matus-Amat P; Higgins EA; Sprunger D; Wright-Hardesty K; Rudy JW
Behav Neurosci; 2007 Aug; 121(4):721-31. PubMed ID: 17663597
[TBL] [Abstract][Full Text] [Related]
24. NMDA receptor blockers prevents the facilitatory effects of post-training intra-dorsal hippocampal NMDA and physostigmine on memory retention of passive avoidance learning in rats.
Jafari-Sabet M
Behav Brain Res; 2006 Apr; 169(1):120-7. PubMed ID: 16443290
[TBL] [Abstract][Full Text] [Related]
25. 4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade.
Al Rahim M; Nakajima A; Saigusa D; Tetsu N; Maruyama Y; Shibuya M; Yamakoshi H; Tomioka Y; Iwabuchi Y; Ohizumi Y; Yamakuni T
Biochemistry; 2009 Aug; 48(32):7713-21. PubMed ID: 19601643
[TBL] [Abstract][Full Text] [Related]
26. The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex.
Resstel LB; Corrêa FM; Guimarães FS
Cereb Cortex; 2008 Sep; 18(9):2027-35. PubMed ID: 18158326
[TBL] [Abstract][Full Text] [Related]
27. MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning.
Gould TJ; McCarthy MM; Keith RA
Behav Pharmacol; 2002 Jul; 13(4):287-94. PubMed ID: 12218509
[TBL] [Abstract][Full Text] [Related]
28. Latent inhibition of cued fear conditioning: an NMDA receptor-dependent process that can be established in the presence of anisomycin.
Lewis MC; Gould TJ
Eur J Neurosci; 2004 Aug; 20(3):818-26. PubMed ID: 15255992
[TBL] [Abstract][Full Text] [Related]
29. Effects of the M1 muscarinic antagonist dicyclomine on emotional memory retrieval.
Soares JC; Perfetto JG; Antonio BB; Oliveira MG
Behav Neurosci; 2016 Feb; 130(1):29-35. PubMed ID: 26619084
[TBL] [Abstract][Full Text] [Related]
30. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments.
Thompson LT; Disterhoft JF
J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403
[TBL] [Abstract][Full Text] [Related]
31. Effects of complete immunotoxin lesions of the cholinergic basal forebrain on fear conditioning and spatial learning.
Frick KM; Kim JJ; Baxter MG
Hippocampus; 2004; 14(2):244-54. PubMed ID: 15098729
[TBL] [Abstract][Full Text] [Related]
32. Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory.
Fornari RV; Moreira KM; Oliveira MG
Learn Mem; 2000; 7(5):287-92. PubMed ID: 11040260
[TBL] [Abstract][Full Text] [Related]
33. The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-D-aspartate or its noncompetitive antagonist MK-801 into the ventral hippocampus.
Zhang WN; Bast T; Feldon J
Behav Brain Res; 2001 Nov; 126(1-2):159-74. PubMed ID: 11704261
[TBL] [Abstract][Full Text] [Related]
34. Role of hippocampal NMDA receptors in trace eyeblink conditioning.
Sakamoto T; Takatsuki K; Kawahara S; Kirino Y; Niki H; Mishina M
Brain Res; 2005 Mar; 1039(1-2):130-6. PubMed ID: 15781054
[TBL] [Abstract][Full Text] [Related]
35. MK-801 prevents the increased NMDA-NR1 and NR2B subunits mRNA expression observed in the hippocampus of rats tolerant to diazepam.
Almirón RS; Pérez MF; Ramírez OA
Brain Res; 2004 May; 1008(1):54-60. PubMed ID: 15081382
[TBL] [Abstract][Full Text] [Related]
36. NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice.
Bardgett ME; Boeckman R; Krochmal D; Fernando H; Ahrens R; Csernansky JG
Brain Res Bull; 2003 Apr; 60(1-2):131-42. PubMed ID: 12725901
[TBL] [Abstract][Full Text] [Related]
37. Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning.
Borelli KG; Gárgaro AC; dos Santos JM; Brandão ML
Neurosci Lett; 2005 Oct; 387(2):105-10. PubMed ID: 16085359
[TBL] [Abstract][Full Text] [Related]
38. Modulation of ethanol state-dependent learning by dorsal hippocampal NMDA receptors in mice.
Rezayof A; Sharifi K; Zarrindast MR; Rassouli Y
Alcohol; 2008 Dec; 42(8):667-74. PubMed ID: 18774674
[TBL] [Abstract][Full Text] [Related]
39. Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning.
Quinn JJ; Loya F; Ma QD; Fanselow MS
Hippocampus; 2005; 15(5):665-74. PubMed ID: 15959918
[TBL] [Abstract][Full Text] [Related]
40. L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning.
Chess AC; Landers AM; Bucci DJ
Behav Brain Res; 2009 Aug; 201(2):325-31. PubMed ID: 19428652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
